Indication

Constrictive Bronchiolitis

1 clinical trial

1 product

Product

Liposomal Cyclosporine A

Clinical trial

A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow® Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant

Status: , Estimated PCD: 2024-09-01